Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications

被引:48
作者
Adams, Ted D. [1 ,2 ]
Arterburn, David E. [3 ]
Nathan, David M. [4 ,5 ]
Eckel, Robert H. [6 ]
机构
[1] Univ Utah, Intermt Healthcare, Intermt LiVe Well Ctr, Salt Lake City, UT USA
[2] Univ Utah, Div Cardiovasc Genet, Salt Lake City, UT USA
[3] Grp Hlth Res Inst, Seattle, WA USA
[4] Massachusetts Gen Hosp, Ctr Diabet, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Boston, MA USA
[6] Univ Colorado, Sch Med, Div Endocrinol Metab & Diabet, Aurora, CO USA
基金
美国国家卫生研究院;
关键词
Y GASTRIC BYPASS; MORBIDLY OBESE-PATIENTS; LONG-TERM MORTALITY; BARIATRIC SURGERY; WEIGHT-LOSS; FOLLOW-UP; DIABETES-MELLITUS; CARDIOVASCULAR-DISEASE; INSULIN SENSITIVITY; LIFE-STYLE;
D O I
10.2337/dc16-0157
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Understanding of the long-term clinical outcomes associated with bariatric surgery has recently been advanced. Research related to the sequelae of diabetesin particular, long-term microvascular and macrovascular complicationsin patients who undergo weight-loss surgery is imperative to this pursuit. While numerous randomized control trials have assessed glucose control with bariatric surgery compared with intensive medical therapy, bariatric surgery outcome data relating to microvascular and macrovascular complications have been limited to observational studies and nonrandomized clinical trials. As a result, whether bariatric surgery is associated with a long-term reduction in microvascular and macrovascular complications when compared with current intensive glycemic control therapy cannot be determined because the evidence is insufficient. However, the consistent salutary effects of bariatric surgery on diabetes remission and glycemic improvement support the opportunity (and need) to conduct high-quality studies of bariatric surgery versus intensive glucose control. This review provides relevant background information related to the treatment of diabetes, hyperglycemia, and long-term complications; reports clinical findings (to date) with bariatric surgery; and identifies ongoing research focusing on long-term vascular outcomes associated with bariatric surgery.
引用
收藏
页码:912 / 923
页数:12
相关论文
共 97 条
[1]   Long-term mortality after gastric bypass surgery [J].
Adams, Ted D. ;
Gress, Richard E. ;
Smith, Sherman C. ;
Halverson, R. Chad ;
Simper, Steven C. ;
Rosamond, Wayne D. ;
LaMonte, Michael J. ;
Stroup, Antoinette M. ;
Hunt, Steven C. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (08) :753-761
[2]   All-Cause and Cause-Specific Mortality Associated with Bariatric Surgery: A Review [J].
Adams, Ted D. ;
Mehta, Tapan S. ;
Davidson, Lance E. ;
Hunt, Steven C. .
CURRENT ATHEROSCLEROSIS REPORTS, 2015, 17 (12)
[3]   Relation between degree of weight loss after bariatric surgery and reduction in albuminuria and C-reactive protein [J].
Agrawal, Varun ;
Krause, Kevin R. ;
Chengelis, David L. ;
Zalesin, Kerstyn C. ;
Rocher, Leslie L. ;
McCullough, Peter A. .
SURGERY FOR OBESITY AND RELATED DISEASES, 2009, 5 (01) :20-26
[4]   Improvement and stabilization of chronic kidney disease after gastric bypass [J].
Alexander, J. Wesley ;
Goodman, Hope R. ;
Hawver, Lisa R. Martin ;
Cardi, Michael A. .
SURGERY FOR OBESITY AND RELATED DISEASES, 2009, 5 (02) :237-241
[5]   Achievement of Goals in U.S. Diabetes Care, 1999-2010 [J].
Ali, Mohammed K. ;
Bullard, Kai McKeever ;
Saaddine, Jinan B. ;
Cowie, Catherine C. ;
Imperatore, Giuseppina ;
Gregg, Edward W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (17) :1613-1624
[6]  
American Diabetes Association, 2010, DIABETES CARE, V33, pS11, DOI DOI 10.2337/dc10-S011
[7]   Weight loss independently predicts urinary albumin excretion normalization in morbidly obese type 2 diabetic patients undergoing bariatric surgery [J].
Amor, Antonio ;
Jimenez, Amanda ;
Moize, Violeta ;
Ibarzabal, Ainitze ;
Flores, Lilliam ;
Lacy, Antonio M. ;
Vidal, Josep .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2013, 27 (06) :2046-2051
[8]  
[Anonymous], NEW ENGL J MED
[9]  
[Anonymous], DECISION MEMO SURG D
[10]  
[Anonymous], IFD DIAB ATL 6 ED